BusinessVital Therapies Appoints Russell J. Cox as Chief Executive Officer and Board Member Effective January 3, 2018By Nasdaq OMXDec 4, 2017, 9:29 PM UTC
BusinessNetworkNewsWire Announces Publication on Investment Opportunities Created by Ongoing R&D of Medical CannabisBy Nasdaq OMXDec 4, 2017, 1:30 PM UTC
BusinessBeyondSpring’s Lead Asset, Plinabulin, Recognized as 2017 National Science and Technology Major Project in ChinaBy Nasdaq OMXDec 4, 2017, 12:00 PM UTC
BusinessKraig Biocraft Laboratories Expands Team With Appointment of New Molecular BiologistBy Nasdaq OMXDec 4, 2017, 11:05 AM UTC
BusinessCytokinetics Announces Results of VITALITY-ALS to be Presented at the International Symposium on ALS/MNDBy Nasdaq OMXDec 1, 2017, 9:00 PM UTC
BusinessAxsome Therapeutics Announces $9.5 Million Registered Direct Offering Priced At-the-MarketBy Nasdaq OMXDec 1, 2017, 12:00 PM UTC
BusinessBeyondSpring Initiates Global Phase 2/3 Trial with Plinabulin in China for the Prevention of Chemotherapy-Induced Neutropenia to Demonstrate SuperiorityBy Nasdaq OMXNov 30, 2017, 2:58 PM UTC
BusinessNew Publication Shows Respiratory Decline Correlated With Disease Progression in People Living With ALSBy Nasdaq OMXNov 30, 2017, 12:30 PM UTC
